330 Million! Intelligently Control The Future Of Heart
With the increasing prevalence of cardiovascular diseases, how to use science and technology to improve the diagnosis and treatment effect has become the focus of the medical community. According to statistics from the World Health Organization, cardiovascular disease has become one of the leading causes of death worldwide. In China, the prevalence and mortality of cardiovascular diseases have also shown an upward trend year by year. As of now, the number of cardiovascular disease patients in China has reached 330 million. Faced with this grim situation, the medical community continues to explore new diagnosis and treatment technologies and methods in order to improve the treatment effect of cardiovascular diseases and the quality of life of patients.
On September 27-28, 2024, the highly anticipated "First Beijing-North Cardiovascular Innovation and Application Conference" will be held in Beijing. With "innovation, collaboration, integration, and practice" as its core purpose, this conference is based on the advantages of Beijing-North, connects with the international frontier, and focuses on the latest technology and clinical applications in the cardiovascular field. The conference covers more than 40 topics such as cardiovascular bioengineering, coronary heart disease, heart failure, lipid management, magnetocardiography, intracavitary imaging, critical care and interventional nursing, artificial intelligence, etc., and invites well-known experts from home and abroad to have in-depth exchanges and discuss how cutting-edge research can better serve daily diagnosis and treatment and improve the level of primary medical care .
The conference was hosted by the Beijing Chronic Disease Prevention and Health Education Research Association, the Changping District Cardiovascular Intervention Quality Control and Improvement Center, and the Beijing Changping District Cardiovascular Disease Quality Control and Improvement Center, and was hosted by Beijing Jishuitan Hospital Affiliated to Capital Medical University and co-organized by Beijing Changping District Shahe Hospital. The conference was held online and offline. The conference had many highlights, including high-level academic speeches, surgical demonstrations, immersive experiences of cutting-edge technology, and the release of the AI version of the guide. As a pioneer in vascular interventional surgical robots, WeMed Medical will bring its cutting-edge technological achievements and innovative solutions to this event, bringing a feast of smart medical care to the participants.
Vascular interventional surgery robot Accurate, intelligent and efficient
Innovation is the key force driving medical progress. In the field of diagnosis and treatment of cardiovascular diseases, WeMed Medical has always been at the forefront of the industry. The company has a team of top medical experts, engineers and scientific researchers who have rich industry experience and profound professional knowledge. In the process of product development, WeMed Medical always adheres to the patient's needs as the guide, focusing on the practicality and convenience of the product. At the same time, we have also established close cooperative relations with many well-known medical institutions and scientific research institutions to jointly promote scientific and technological progress in the cardiovascular field.
WeMed Medical has made breakthrough progress in the research and development of vascular interventional surgical robots. This interventional surgical robot has precise robotic arm control and intelligent perception, which realizes the automation, intelligence and bionics of the surgical process. In addition, it can also integrate DSA's advanced image processing system. This technological breakthrough not only improves the accuracy and safety of the surgery, but also greatly shortens the operation time and reduces the patient's postoperative complications and recovery period. It is worth mentioning that the robot also supports remote diagnosis and treatment, allowing doctors to perform surgical treatment on patients in other places, breaking geographical restrictions and achieving a balanced distribution of high-quality medical resources.
WeMed Medical has been continuously investing in research and development, and is committed to applying the most advanced technology to clinical practice. WeMed Medical's vascular interventional surgery robot has established scientific research cooperation with many tertiary hospitals across the country, with a high clinical success rate and good feedback. At present, this interventional surgery robot is also the first domestically produced interventional surgery robot to pass the green channel of the National Medical Products Administration.
"Eye-hand-brain" collaboration
"Heart" diagnosis and treatment intelligence benchmark
WeMed Medical's "eye, hand, and brain" collaborative interventional diagnosis and treatment solution has pushed the concept of precision medicine to a new height. The solution uses the DSA system as the "eye" to provide ultra-high-definition, real-time dynamic vascular images; the vascular interventional surgical robot as the "hand" to achieve accurate and error-free surgical operations; and the intelligent image processing platform as the "brain" to provide personalized surgical plans and decision-making support. The three work closely together to form an efficient and intelligent diagnosis and treatment system, which not only improves the efficiency and safety of diagnosis and treatment, but also promotes the optimal allocation and sharing of medical resources.
Digital subtraction angiography (DSA) technology provides clear "vision" for our surgical robots . It can capture dynamic changes in blood vessels in real time and provide precise navigation for surgery. The interventional surgical robot is responsible for performing precise surgical operations , can accurately execute the doctor's instructions, perform complex surgical operations, and ensure the accuracy and stability of the surgery through millimeter-level operations. The intelligent image processing platform is responsible for intelligent analysis and processing of image data . It uses advanced artificial intelligence algorithms and big data analysis technology to quickly and accurately identify the area and degree of vascular lesions. At the same time, the platform also has the ability of self-learning and optimization, which can continuously improve the accuracy and efficiency of diagnosis. Through seamless docking with DSA technology and interventional surgical robots, the intelligent image processing platform provides strong technical support for the entire diagnosis and treatment process.
Integration of Industry, University and Research
Smart innovation acceleration
WeMed Medical is well aware that the in-depth development of the industry requires joint promotion from multiple parties. Therefore, we actively seek cooperation and exchanges with partners from all parties. At the "First Beijing North Cardiovascular Innovation and Application Conference", WeMed Medical discussed the development trends and cutting-edge technologies in the cardiovascular field with experts, scholars and industry leaders from all over the country. We believe that by strengthening cooperation and exchanges, we can jointly promote the progress and development of cardiovascular medicine and bring good news to more patients.
WeMed Medical has always adhered to the development model of deep integration of industry, academia and research, and has established long-term cooperative relationships with many top medical institutions and scientific research institutes at home and abroad to jointly carry out scientific research projects and overcome technical difficulties. Through the close cooperation between industry, academia and research, we continue to transform the latest scientific research results into clinical applications, bringing patients better quality and more efficient medical services.
In the future development, WeMed Medical will continue to uphold the concept of open cooperation, actively seek cooperation opportunities with more partners, deeply practice the industry-university-research development model, jointly explore new technologies, new models and new applications, promote continuous innovation and development in the cardiovascular field, and make smart high-end medical equipment and its full-process solutions benefit thousands of households. At the same time, we will also pay attention to patient needs and market changes, continuously optimize product and service quality, and provide patients with better quality and more convenient medical services.
